Arbutus Biopharma Corporation (NASDAQ:ABUS) is a publicly-traded biopharmaceutical company dedicated to discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection, a disease of the liver caused by hepatitis B virus (HBV).

Biotechnology

Arbutus Biopharma

Michael McElhaugh

Ganapati Reddy Pamulapati

Shannon Briscoe

Michael Child

Catherine Coffey Ross

Karen Sims

Michael J. Sofia Phd

Elizabeth Howard

David C. Hastings

The executive team at Arbutus Biopharma has experience in various aspects of the pharmaceutical industry, from heading clinical virology at Tibotec to being the Chief Scientific Officer at Arbutus Biopharma. The team is also educated in various fields related to their work, from Virology and Molecular Biology to Chemistry and Pharmaceutical Management.

CEO and Executive Team

Board of Directors

Leadership Team

CEO and Executive Team

About

Team members

Other teams at Arbutus Biopharma

Board of Directors

Leadership Team